Darbepoetin alfa biosimilar (CJ Healthcare)
阿法达贝泊汀生物类似药 (CJ Healthcare)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameDarbepoetin alfa biosimilar (CJ Healthcare)
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCj Cheiljedang Corp
China Registration ClassN/A
Develop Information
Active CompaniesCj Cheiljedang CorpNorth China Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A